SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-404506
Filing Date
2014-11-10
Accepted
2014-11-10 06:40:25
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d818121d10q.htm 10-Q 682041
2 EX-10.1 d818121dex101.htm EX-10.1 23637
3 EX-31.1 d818121dex311.htm EX-31.1 6411
4 EX-31.2 d818121dex312.htm EX-31.2 6462
5 EX-32 d818121dex32.htm EX-32 4172
  Complete submission text file 0001193125-14-404506.txt   8188978

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dndn-20140930.xml EX-101.INS 1589167
7 XBRL TAXONOMY EXTENSION SCHEMA dndn-20140930.xsd EX-101.SCH 54302
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dndn-20140930_cal.xml EX-101.CAL 50888
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dndn-20140930_def.xml EX-101.DEF 145494
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dndn-20140930_lab.xml EX-101.LAB 374334
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dndn-20140930_pre.xml EX-101.PRE 319167
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Filer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35546 | Film No.: 141206523
SIC: 2834 Pharmaceutical Preparations